Abstract: Examples described herein any include a surgical module for use within the surgical system. The surgical module may include a first port connected to a surgical hub; a second port connected to an additional surgical module; and a controller. The controller may be configured to receive surgical data; determine if the surgical data is a first type of data or a second type of data; and instruct the surgical module to send the surgical data to the first port if the surgical data is the first type of data or to the second port if the surgical data is the second type of data.

Abstract: The present invention relates to a compound for use in detecting “reader” and “eraser” proteins of lysine lipoylation. The present invention provides an affinity-based probe, referred to herein as “KPlip”, capable of interrogating the lipoylated peptide/protein interactions under native cellular environments. The chemical probe allows for the identification of potential regulators of lysine lipoylation, thus uncovering new biology related to lipoylation. There is also provided a method of using the compound to identifying proteins that interact with lipoylated proteins.

Abstract: Disclosed is a method for measuring activated partial thromboplastin time, the method comprising: mixing: a blood sample; a first reagent comprising an ellagic acid compound and a compound represented by Formula (I); and a second regent comprising a calcium ion; and measuring activated partial thromboplastin time using the mixture prepared in the mixing step, wherein the compound represented by Formula (I) is shown below wherein X is a hydrogen atom, —(C?O)—Y, or —(C?O)—OZ, Y is a hydroxyl group, a hydrogen atom, a linear or branched alkyl group having a carbon number of 1 or more and 6 or less, or a phenyl group, and Z is an alkali metal.

Abstract: Disclosed are a recombinant microorganism for producing a hydrophobic material, which is subjected to cell-membrane engineering in order to be imparted with at least one characteristic among an increase in a cell-membrane area, an increase in formation and secretion of an outer membrane vesicle, and an increase in formation of an inner membrane vesicle, and a cell-membrane engineering method for preparation thereof, whereby an insoluble hydrophobic material can be produced with high efficiency, the recombinant microorganism for high-efficiency production of carotenoids or violacein analogues is useful for producing natural pigments, antioxidants, antibiotics, cosmetic additives, anticancer agents, food additives, or nutritional supplements, and the natural pigment production technology developed herein achieves a great increase in production ability.

Abstract: The invention relates to methods, systems, and computer-readable media related to a system having a plurality of users, designed to display a user-customized subset of item and/or provider information to the user.

Abstract: Disclosed herein are methods for presenting therapy events on a continuous, time-based data feed. An algorithm for arranging data on the feed can position icons on the feed with information regarding therapy events at a time each event occurred without blocking or interfering with the data feed, including when the data feed is scrolled, zoomed, or otherwise repositioned. The algorithm can include clustering, buffering and affinity components. The clustering component can combine different events occurring at the same time into a single event and keep those events visually together on the data feed. The buffering component can provide a buffer around each event so there is no overlapping of depicted events. The affinity component provides an affinity for placing events as closed to a CGM trend line on the data feed as possible in view of the positioning of other events.

Abstract: A computer system for identifying medical care providers outside a process-of-care standard for a field of health care is configured to perform steps that include retrieving claim line item information including procedure/service codes, and retrieving definitions for marker code groups associated with each of a set of medical conditions; deriving, for each marker-condition pair, an actual rate of utilization of the marker code group for episodes of the associated medical condition; and assigning a status to each marker-condition pair in response to the actual rate of utilization respectively exceeding or not exceeding a target rate. The steps also include aggregating the statuses across the marker-condition pairs to obtain an overall score, and causing an output to be displayed in a viewable format. The output includes the overall score, each marker-condition pair of the set of medical conditions, and the status for each marker-condition pair of the set of medical conditions.

Abstract: A dialysis (e.g., hemodialysis or peritoneal dialysis) machine is instantiated with a blockchain application to help safeguard the machine from malicious attacks and provide a reviewable transaction log. The blockchain application may operate on a component level within a single dialysis machine or multiple dialysis machines that collectively operate within a blockchain community. Multiple rules and regulations may be utilized among the dialysis machines or dialysis machine components to ensure authorized instructions alter dialysis machine operations. The verification process can occur, for example, by discrete dialysis machine components verifying the instruction with a remote service or discrete dialysis machines verifying the instruction with the remote service. When a pre-set number of components or dialysis machines verify the instruction and develop a consensus, such as 50%, 75%, 90%, etc., the target component or machine executes the instruction.

Abstract: The present invention provides engineered methionine gamma lyase polypeptides and compositions thereof. The engineered methionine gamma lyase polypeptides have been optimized to provide improved thermostability, protease stability, and stability under a range of pH conditions, including acidic (pH<7) conditions. The present invention also relates to the use of the compositions comprising the engineered methionine gamma lyase polypeptides for therapeutic purposes.

Abstract: System for generating a body degradation reduction program including a computing device configured to receive at least a degradation marker, retrieve a body degradation profile as a function of the at least a degradation marker, assign the body degradation profile to a degradation category, identify, using the degradation category and the body degradation profile, a plurality of lifestyle elements, wherein identifying the plurality of lifestyle elements includes calculating a plurality of lifestyle element amounts as a function of a respective effect of each of a plurality of lifestyle elements on the body degradation profile as a function of the degradation category, identifying the plurality of lifestyle elements as a function of the plurality of lifestyle element amounts, and generate a body degradation reduction program, using the plurality of lifestyle elements, wherein the body degradation reduction program includes a frequency and a magnitude of engagement of the plurality of lifestyle elements.

Abstract: Methods and systems for managing patient compliance with a treatment are disclosed. An example method can comprise receiving data indicative of a time on active therapy. The method can comprise receiving data indicative of a pressure associated with the time on active therapy. The method can further comprise determining a patient compliance factor based on the data indicative of the time on active therapy and the data indicative of the pressure associated with the time on active therapy. The method can comprise determining a graphical object modifier based on the patient compliance factor and displaying a graphical object based on the graphical object modifier.

Abstract: A use of a cell wall or a cell wall skeleton of Rhodococcus ruber in preparing a drug for treating a thermal injury. The thermal injury comprises a burn, a scald and a chemical burn. Applying the Rhodococcus ruber product to a subject has a good therapeutic effect on a thermal injury and has no side effects.

Abstract: Systems, devices, user interfaces, and methods for managing patient conditions. A system for monitoring and/or managing a patient suffering from a brain condition may include a controller obtaining and/or storing data related to one or more monitored patient parameters contributing to the brain condition of the patient and displaying values of the one or more monitored patient parameters in trend lines over time on a user interface. The displayed trend lines may represent values of ventricular CSF volume, values of IVH volume, total ventricular volume in the brain, and/or values of other suitable parameters. The data related to the one or more monitored patient parameters may include images of the patient's brain and/or data derived from images of the patient's brain and/or suitable patient data.

Abstract: Medication security and healthcare privacy analytics systems are described that enable users to search for and process stored healthcare environment data. The medication security and healthcare privacy analytics systems receive and correlate data from a plurality of data sources, including medication dispensing systems, healthcare employee records, and patient records. The medication security and healthcare privacy analytics systems generate a plurality of feature vectors from processed healthcare environment data. The visualizations are created using datasets generated by clustering algorithms and can indicate those feature vectors from the plurality of feature vectors whose data indicate anomalous interactions with various systems (e.g., indicative of unexpected or non-customary events).

Abstract: A system, device, and method for collecting user information. An image and metadata associated with the image are captured utilizing a wireless device. The image and the metadata are associated with a device incapable of communication. User information associated with the device is determined. The user information is characterized in context of historical data. The user information is distributed from the wireless device to one or more devices associated with the user information.

Abstract: An example computer-implemented method of increasing veterinary health care compliance includes receiving information indicating that an animal patient concluded a visit at a veterinary practice, in response accessing diagnostic test results for the animal patient, based on the diagnostic test results creating a pet owner profile for an owner of the animal patient, matching the pet owner profile with a stored message and stored information relating to a product associated with recommended treatment for the animal patient, sending an electronic message to a second computing device associated with the owner of the animal patient that includes the stored message and the stored information relating to the product associated with recommended treatment for the animal patient, receiving a report indicating whether the owner of the animal patient obtained the product associated with recommended treatment for the animal patient, and updating the pet owner profile to be indicative of the report.

Abstract: A computer-implemented method improves efficacy of diabetes self-management to obtain a measurement message and/or contextual activity information used to determine a suitable insulin dosage to treat a patient. The method includes simulating a health coach in a natural conversation to obtain a measurement of the patient's blood-glucose level, processing the measured blood-glucose level with a personalized insulin titration algorithm to determine an insulin dosage recommendation, and generating an electronic signal configured to cause a corresponding action to be performed by a computing device.

Abstract: Methods and apparatus, including computer program products, are provided for processing analyte data. In some example implementations, a method may include generating glucose sensor data indicative of a host's glucose concentration using a glucose sensor; calculating a glycemic variability index (GVI) value based on the glucose sensor data; and providing output to a user responsive to the calculated glycemic variability index value. The GVI may be a ratio of a length of a line representative of the sensor data and an ideal length of the line. Related systems, methods, and articles of manufacture are also disclosed.

Abstract: The invention relates to methods, systems, and computer-readable media related to a system having a plurality of users, designed to display a user-customized subset of item and/or provider information to the user.

Abstract: Various systems and methods for tracking surgical procedure costs are disclosed. A computer system, such as surgical hub, is configured to be communicably coupled to a plurality of surgical devices. The computer system can be programmed to identify the surgical devices that are being utilized during a surgical procedure via perioperative data received from the surgical devices and then calculate the total cost associated with the surgical devices used in the surgical procedure. The total cost can include an aggregation of the maintenance costs of each of the reusable surgical devices and the replacement costs of the nonreusable surgical devices consumed during the surgical procedure.